Dietary vitamin E modulates differential gene expression in the rat hippocampus: Potential implications for its neuroprotective properties

Nutritional Neuroscience

Volumn 8, Issue 1, 2005, Pages 21-29

  Rota, Cristina ^a   Rimbach, Gerald ^b   Minihane, Anne Marie ^a   Stoecklin, Elisabeth ^c   Barella, Luca ^c  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF KIEL   (Germany)

^c DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Alzheimer's disease (AD); Amyloid beta; Brain; Gene; Hippocampus; Vitamin E

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; NERVE GROWTH FACTOR;

ALPHA TOCOPHEROL DEFICIENCY; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; DOPAMINERGIC TRANSMISSION; DRUG MECHANISM; GENE CONTROL; GENE EXPRESSION; HIPPOCAMPUS; HORMONE METABOLISM; MALE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

ANIMALS; DIET; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; VITAMIN E; VITAMIN E DEFICIENCY;

ANIMALIA;

EID: 18344389020     PISSN: 1028415X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10284150400027123     Document Type: Article

References (61)

1. Arvat E, Broglio F, Ghigo E. 2000. Insulin-Like growth factor I: Implications in aging. Drugs Aging 16:29-40.
2. Barella L, Muller PY, Schlachter M, Hunziker W, Stöcklin E, Spitzer V, Meier N, de Pascual-Teresea S, Minihane A-M, Rimbach G. 2004. Identification of hepatic molecular mechanism of action of alpha-tocopherol using global gene expression profile analysis in rats. Biochim Biophys Acta 1689(1):66-74.
3. Behl C, Davis J, Cole GM, Schubert D. 1992. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 186:944-950.
4. Belandia B, Latasa MJ, Villa A, Pascual A. 1998. Thyroid hormone negatively regulates the transcriptional activity of the beta-amyloid precursor protein gene. J Biol Chem 273:30366-30371.
5. Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ. 1996. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem 271:32916-32922.
6. Borg JP, Yang Y, De Taddeo-Borg M, Margolis B, Turner RS. 1998. The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion. J Biol Chem 273:14761-14766.
7. Boscoboinik D, Szewczyk A, Azzi A. 1991. Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch Biochem Biophys 286:264-269.
8. Busiguina S, Fernandez AM, Barrios V, Clark R, Tolbert DL, Berciano J, Torres-Aleman I. 2000. Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiol Dis 7:657-665.
9. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I. 2002. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 8:1390-1397.
10. Christensen EI, Birn H. 2002. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3:256-266.
11. DeMattos RB, O'Dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR, Paul SM, Aronow BJ, Holtzman DM. 2002. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 99:10843-10848.
12. Dore S, Kar S, Quirion R. 1997. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci USA 94:4772-4777.
13. Duffy JF, Zeitzer JM, Rimmer DW, Klerman EB, Dijk DJ, Czeisler CA. 2002. Peak of circadian melatonin rhythm occurs later within the sleep of older subjects. Am J Physiol Endocrinol Metab 282:E297-E303.
14. Gohil K, Schock BC, Chakraborty AA, Terasawa Y, Raber J, Farese Jr., RV, Packer L, Cross CE, Traber MG. 2003. Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in α-tocopherol transfer protein. Free Radic Biol Med 35(11):1343-1354.
15. Goss-Sampson MA, Kriss A, Muller DPR. 1990. A longitudinal study of somatosensory, brainstem auditory and peripheral sensory-motor conduction during vitamin E deficiency in the rat. J Neurol Sci 100:79-84.
16. Grundman M, Delaney P. 2002. Antioxidant strategies for Alzheimer's disease. Proc Nutr Soc 61:191-202.
17. Hammad SM, Ranganathan S, Loukinova E, Twal WO, Argraves WS. 1997. Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide. J Biol Chem 272:18644-18649.
18. Harding AE. 1987. Vitamin E and the nervous system. Crit Rev Neurobiol 3:89-103.
19. Hayton SM, Kriss A, Wade A, Muller DPR. 2003. The effects of different levels of all-rac- and RRR-α-tocopheryl acetate (vitamin E) on visual function in rats. Clin Neurophysiol 114:2124-2131.
20. Hemby SE, Trojanowski JQ, Ginsberg SD. 2003. Neuron-specific age-related decreases in dopamine receptor subtype mRNAs. J Comp Neurol 456:176-183.
21. Hock CH, Heese K, Olivieri G, Hulette CH, Rosenberg C, Nitsch RM, Otten U. 2000. Alterations in neurotrophins and neurotrophin receptors in Alzheimer's disease. J Neural Transm 59(Suppl.):171-174.
22. Jain SK, Palmer M. 1997. The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med 22:593-596.
23. Jones SR, Joseph JD, Barak LS, Caron MG, Wightman RM. 1999. Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 73:2406-2414.
24. Joyce JN, Ryoo HL, Beach TB, Caviness JN, Stacy M, Gurevich EV, Reiser M, Adler CH. 2002. Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: Role of D3 and not D2 receptors. Brain Res 955:138-152.
25. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM. 2000. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 53:733-737.
26. Kontush A, Mann U, Arlt S, Ujeyl A, Luhrs C, Muller-Thomsen T, Beisiegel U. 2001. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Radic Biol Med 31:345-354.
27. Korytko AI, Cuttler L. 2001. Regulation of GHRH receptor gene expression in the neonatal and adult rat pituitary. Growth Horm IGF Res 11:282-288.
28. Kulik G, Weber MJ. 1998. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol Cell Biol 18:6711-6718.
29. Lahiri DK. 1999. Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types. J Pineal Res 26:137-146.
30. Machlin LJ, Filipski R, Nelson JS, Horn LR, Brin M. 1977. Effects of a prolonged vitamin E deficiency. J Nutr 107:1200-1208.
31. Marieb EN. 1991. Essentials of Human Anatomy and Physiology. 3rd Ed., Redwood City, CA: Benjamin/Cummings.
32. Matsubara E. Bryant-Thomas T, Pacheco Quinto J, Henry TL, Poeggeler B, Herbert D, Cruz-Sanchez F, Chyan YJ, Smith MA, Perry G, Shoji M, Abe K, Leone A, Grundke-Ikbal I, Wilson GL, Ghiso J, Williams C, Refolo LM, Pappolla MA. 2003. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J Neurochem 85:1101-1108.
33. Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey AI. 1997. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol 41:530-539.
34. Morris MC, Beckett LA, Scherr PA, Hebert LE, Bennett DA, Field TS, Evans DA. 1998. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord 12:121-126.
35. Muller DPR, Goss-Sampson MA. 1990. Neurochemical, neurophysiological, and neuropathological studies in vitamin E deficiency. Crit Rev Neurobiol 5:239-263.
36. Muller DPR, Lloyd JK, Wolff OH. 1983. Vitamin E and neurological function. Lancet 1:225-228.
37. Nelson JS, Fitch CD, Fischer VW, Broun GO, Chou AC. 1981. Progressive neuropathologic lesions in vitamin E deficient Rhesus monkeys. J Neuropathol Exp Neurol 40:166-186.
38. Niikura T, Hashimoto Y, Okamoto T, Abe Y, Yasukawa T, Kawasumi M, Hiraki T, Kita Y, Terashita K, Kouyama K, Nishimoto I. 2001. Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner. J Neurosci 21:1902-1910.
39. Nunan J, Small DH. 2002. Proteolytic processing of the amyloid-beta protein precursor of Alzheimer's disease. Essays Biochem 38:37-49.
40. Ohashi Y, Okamoto N, Uchida K, Iyo M, Mori N, Morita Y 1997. Differential pattern of the circadian rhythm of serum melatonin in young and elderly healthy subjects. Biol Signals 6:301-306.
41. Raevskii KS. 1998. Functional role and pharmacological regulation of the dopaminergic system of the brain. Vestn Ross Akad Med Nauk 8:19-24.
42. Reddy VP, Obrenovich ME, Atwood CS, Perry G, Smith MA. 2002. Involvement of Maillard reactions in Alzheimer disease. Neurotox Res 4:191-209.
43. Rota C, Barella L, Minihane A-M, Stöcklin E, Rimbach G. 2004. Dietary alpha-tocopherol affects differential gene expression in rat testes. IUBMB Life 56(4):277-280.
44. Roy S, Lado BH, Khanna S, Sen CK. 2002. Vitamin E sensitive genes in the developing rat fetal brain: A high-density oligonucleotide microarray anaylsis. FEBS Lett 530:17-23.
45. Saito A, Nagai R, Tanuma A, Hama H, Cho K, Takeda T, Yoshida Y, Toda T, Shimizu F, Horiuchi S, Gejyo F. 2003. Role of megalin in endocytosis of advanced glycation end products: Implications for a novel protein binding to both megalin and advanced glycation end products. J Am Soc Nephrol 14:1123-1131.
46. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336:1216-1222.
47. Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z. 1998. Advanced glycation end products in Alzheimer's disease and other neurodegenerative disease. Am J Pathol 153:1149-1155.
48. Sastre M, Turner RS, Levy E. 1998. X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion. J Biol Chem 273:22351-22357.
49. Savaskan E, Olivieri G, Meier F, Brydon L, Jockers R, Ravid R, Wirz-Justice A, Muller-Spahn F. 2002. Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients. J Pineal Res 32:59-62.
50. Siler U, Barella L, Spitzer V, Schnorr J, Lein M, Goralczyk R, Wertz K. 2004. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J 18(9):1019-1021.
51. Tachiiri S, Sasai K, Oya N, Hiraoka M. 2000. Enhanced cell killing by overexpression of dominant-negative phosphatidylinositol 3-kinase subunit, Deltap85, following genotoxic stresses. Jpn J Cancer Res 91:1314-1318.
52. Thompson CC. 1996. Thyroid hormone-responsive genes in developing cerebellum include a novel synaptotagmin and a hairless homolog. J Neurosci 16:7832-7840.
53. Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR. 2002. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol 22:965-977.
54. Usuki F, Yasutake A, Umehara F, Tokunaga H, Matsumoto M, Eto K, Ishiura S, Higuchi I. 2001. In vivo protection of a water-soluble derivative of vitamin E, Trolox, against methylmercury-intoxication in the rat. Neurosci Lett 304:199-203.
55. van Dam PS, Aleman A, de Vries WR, Deijen JB, van der Veen EA, de Haan EH, Koppeschaar HP. 2000. Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Hormone IGF Research 10:S69-S73.
56. van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Zoghbi SS, Baldwin RM, Innis RB. 2002. Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. American Journal of Geriatric Psychiatry 10:36-43.
57. Vatassery GT, Brin MF, Fahn S, Kayden HJ, Traber MG. 1988. Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver and adipose tissue of rats. J Neurochem 51:621-623.
58. von Gall C, Stehle JH, Weaver DR. 2002. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Research 309:151-162.
59. Willnow TE, Hilpert J, Armstrong SA, Rohlmann A, Hammer RE, Burns DK, Herz J. 1996. Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA 93:8460-8464.
60. Yamamura T, Otani H, Nakao Y, Hattori R, Osako M, Imamura H. 2001. IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. Am J Physiol Heart Circ Physiol 280:H1191-H1200.
61. Yokota T, Igarashi K, Uchihara T, Jishage K, Tomita H, Inaba A, Li Y, Arita M, Suzuki H, Mizusawa H, Arai H. 2001. Delayed-onset ataxia in mice lacking alpha -tocopherol transfer protein: Model for neuronal degeneration caused by chronic oxidative stress. Proc Natl Acad Sci USA 98:15185-15190.